Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Funding to train the next generation of cutting-edge antimicrobial resistance researchers has been announced by Ineos Oxford Institute (IOI), the University of Oxford, and the University of Cambridge.

Six new doctoral (PhD or DPhil) places are being created through the shared initiative to lead antimicrobial research teams. Antimicrobial resistance – when microbes, such as bacteria and viruses, outwit our medicines and cause untreatable infections – is already a huge and growing health problem around the world. By 2050 it is estimated that there will be around 10 million global deaths related to drug resistant infections, overtaking the number of cancer related deaths.

Founded at the University of Oxford in 2021, the Ineos Oxford Institute (IOI) was established to tackle this pressing global challenge. It is based at the Sir William Dunn School of Pathology in Oxford, where penicillin was first developed into a viable drug.

The successful candidates will be fully funded for three and a half years.

Professor Chris Schofield, Head of Chemistry at the Ineos Oxford Institute, said: “This new doctoral initiative represents an exciting step towards training the brightest talent to help combat antimicrobial resistance. The first doctoral initiative of its kind in the field, it shows the commitment of both of these leading universities to collaborate on tackling one of the world’s most urgent medical problems.”

Read the full story on the University of Oxford website. 

Similar stories

EAVI2020: The Quest for an HIV Vaccine

In this long read published to coincide with International AIDS Day, we explore how an international collaboration – of which the University of Oxford is a key partner – has boosted HIV vaccine research. We thank our partners at Imperial College London for allowing us to reproduce and abridge this article.

New SMRU building opened in Thailand to provide health care to marginalized populations

The inauguration of a new joint Shoklo Malaria Research Unit (SMRU) and Borderland Health Foundation (BHF) Building took place in Mae Ramat, Thailand, this week.

Smoking increases the risks of 56 diseases in Chinese adults

Smoking increases the risks of 56 diseases and kills more than one million adults in China each year from 22 different causes, according to new research published in The Lancet Public Health.

Success for Oxford researchers in The Genetics Society 2023 Awards

Researchers from Department of Physiology, Anatomy and Genetics, Radcliffe Department of Medicine and Nuffield Department of Population Health have been recgonised in The Genetics Society 2023 awards.

New Studentship honours Enzo Cerundolo

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.